Arovella Therapeutics Limited (ASX:ALA)

Arovella Therapeutics Revenue

In the fiscal year ending June 30, 2025, Arovella Therapeutics had annual revenue of 3.44M AUD with 76.22% growth. Arovella Therapeutics had revenue of 830.00 in the half year ending June 30, 2025, a decrease of -96.85%.

• Revenue: 3.44M
• Revenue Growth: +76.22%
• P/S Ratio: 29.78
• Revenue / Employee: 127.41K
• Employees: 27
• Market Cap: 102.44M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	3.44M	1.49M	76.22%
Jun 30, 2024	1.95M	497.46K	34.20%
Jun 30, 2023	1.45M	1.16M	391.76%
Jun 30, 2022	295.81K	-693.91K	-70.11%
Jun 30, 2021	989.72K	-261.71K	-20.91%